APA (7th ed.) Citation

Y, C., G, P., X, Z., Y, F., C, Y., JM, S., . . . G, S. (2026). Patient-Reported Continuity of GLP-1 Receptor Agonist Therapy. Obesity science & practice, 12(5), e70189. https://doi.org/10.1002/osp4.70189

Chicago Style (17th ed.) Citation

Y, Chen, et al. "Patient-Reported Continuity of GLP-1 Receptor Agonist Therapy." Obesity Science & Practice 12, no. 5 (2026): e70189. https://doi.org/10.1002/osp4.70189.

MLA (9th ed.) Citation

Y, Chen, et al. "Patient-Reported Continuity of GLP-1 Receptor Agonist Therapy." Obesity Science & Practice, vol. 12, no. 5, 2026, p. e70189, https://doi.org/10.1002/osp4.70189.